Maize (Zea mays L.) cultivation is severely affected by Fusarium verticillioides, a highly adaptable systemic pathogen that causes serious yield losses, reduces grain quality, and produces toxic fumonisin, posing significant health risks to humans and livestock. A biological control approach to combating it was investigated. Streptomyces sp. BPTC-684 showed strong inhibitory activity (53.11%) against F. verticillioides BNGO-16, isolated from a diseased tissue sample. Based on physiological and biochemical characteristics, 16S rRNA gene sequencing, average nucleotide identity, and digital DNA–DNA hybridization, strain BPTC-684 is considered a candidate new species belonging to the genus Streptomyces. In silico analysis of Streptomyces sp. BPTC-684 showed that it expresses diverse biosynthetic gene clusters encoding potential bioactive compounds, notably antibiotics (kinamycin, antimycin, fuelimycins A-C, hangtaimycin, and deoxyhangtaimycin) and siderophores (desferrioxamines B and E). In addition, plant growth-promoting behaviors, such as indole-3-acetic acid production; phosphate solubilization; and the production of extracellular lytic enzymes that degrade cellulose, chitin, proteins, amylose, and xylan, were also discovered in Streptomyces sp. BPTC-684. The pot experiments demonstrated that plant height, fresh weight, and dry root weight were increased in strain BPTC-684 by 37.88%, 132.50%, and 223.81%, respectively, compared to F. verticillioides BNGO-16 on the 15th day of infection. These findings suggest that Streptomyces sp. BPTC-684 is a promising biological control agent for inhibiting fungal diseases and promoting maize growth.
Van et al. (Thu,) studied this question.